What is the treatment for viral conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Viral Conjunctivitis

Viral conjunctivitis is primarily self-limited and requires supportive care rather than antimicrobial treatment. 1

Diagnosis and Clinical Features

  • Viral conjunctivitis accounts for approximately 80% of all acute conjunctivitis cases, with adenovirus being the most common causative agent 2
  • Clinical features include:
    • Watery discharge and hyperemia 3
    • Swelling of lid margin and ciliary injection 2
    • Possible preauricular lymphadenopathy 3
    • May be accompanied by systemic symptoms like fever or respiratory symptoms in cases of pharyngoconjunctival fever 3, 4

Treatment Approach

First-Line Management (Supportive Care)

  • No antimicrobial treatment is necessary for uncomplicated viral conjunctivitis as it is self-limited 1, 3
  • Supportive measures include:
    • Artificial tears to provide symptomatic relief 1, 5
    • Cold compresses to reduce inflammation and discomfort 1, 5
    • Topical antihistamines for symptomatic relief 1
    • Oral analgesics for pain management 1

When to Consider Topical Corticosteroids

  • Topical corticosteroids may be helpful in severe cases with:
    • Marked chemosis or eyelid swelling 1
    • Epithelial sloughing 1
    • Membranous conjunctivitis 1
    • Subepithelial infiltrates causing blurring, photophobia, or decreased vision 1
  • Important cautions with corticosteroid use:
    • Close follow-up is mandatory 1
    • May potentially prolong viral shedding (shown in animal models) 1
    • Should be tapered to minimum effective dose 1
    • Consider corticosteroids with poor ocular penetration (fluorometholone, rimexolone, loteprednol) to reduce risk of IOP elevation or cataract formation 1

Treatments to Avoid

  • Antibiotics should be avoided as they provide no benefit for viral infections and may cause toxicity 1
  • Indiscriminate use of topical corticosteroids should be avoided, especially without proper follow-up 1

Infection Control Measures

  • Patient education about the highly contagious nature of viral conjunctivitis is critical 1
  • Advise patients to:
    • Minimize contact with others for 10-14 days from symptom onset in the last affected eye 1
    • Practice strict hand hygiene with frequent handwashing 1, 5, 4
    • Avoid sharing towels, pillows, and personal items 1
    • Disinfect commonly touched surfaces 1, 2
  • Healthcare setting precautions:
    • Consider abbreviated examination in dedicated exam room 1
    • Properly disinfect equipment (especially tonometer tips) using dilute bleach (1:10 concentration) for 5-10 minutes 1
    • Note that 70% isopropyl alcohol wipes are inadequate for disinfection 1
    • Consider deferring IOP measurement unless absolutely necessary 1

Follow-Up Recommendations

  • Patients with severe disease (corneal epithelial ulceration or membranous conjunctivitis) should be re-evaluated within 1 week 1
  • Patients on topical corticosteroids require:
    • Regular monitoring of IOP and pupillary dilation 1
    • Gradual tapering once inflammation is controlled 1
  • Patients not on corticosteroids should return if symptoms persist beyond 2-3 weeks 1
  • Monitor for development of subepithelial infiltrates, which typically appear 1+ weeks after onset 1

When to Refer to an Ophthalmologist

Prompt referral to an ophthalmologist is indicated for patients with:

  • Visual loss 1, 5
  • Moderate or severe pain 1
  • Corneal involvement 1
  • Lack of response to therapy 1
  • History of HSV eye disease 1
  • Immunocompromised status 1, 5

Special Considerations

  • Distinguish viral conjunctivitis from herpes simplex virus (HSV) conjunctivitis, which requires specific antiviral treatment 1, 4
  • Be aware that viral conjunctivitis can occur during pandemics caused by novel pathogens like SARS-CoV-2 4
  • Environmental factors like poor air quality and sanitation may contribute to outbreaks 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Viral Conjunctivitis.

Viruses, 2023

Research

Adenoviral keratoconjunctivitis.

Survey of ophthalmology, 2015

Research

[Viral Conjunctivitis: Findings, Therapy, and Prophylaxis].

Klinische Monatsblatter fur Augenheilkunde, 2023

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.